financetom
LQDA
financetom
/
Healthcare
/
LQDA
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
Liquidia CorporationLQDA
USD
- At close
USD
- Until the end
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
Market Cap
1.11B
Revenue (ttm)
14.00M
Net Income (ttm)
-130.39M
Shares Out
85.30M
EPS (ttm)
-1.66
PE Ratio
n/a
Forward PE
n/a
Dividend
n/a
Ex-Dividend Date
n/a
Volume
404,023
Open
12.46
Previous Close
12.39
Day's Range
12.22 - 12.97
52-Week Range
8.26 - 16.81
Beta
0.22
Analysts
Strong Buy
Price Target
28.33 (+118.43%)
Earnings Date
May 12, 2025
Description >

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States.

Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension.

The company distributes generic treprostinil injection in the United States. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina.

Copyright 2023-2025 - www.financetom.com All Rights Reserved